NCT05681247View on ClinicalTrials.gov

Bioavailability and Bioequivalence of Ezetimibe Tablets in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

December 17, 2017

Primary Completion Date

January 29, 2018

Study Completion Date

March 7, 2018

Conditions
Hyperlipidemias
Interventions
DRUG

ezetimibe tablet

The subjects randomly received single oral administration of ezetimibe tablet 10 mg

DRUG

ezetimibe tablet(Ezetrol ®)

The subjects randomly received single oral administration of ezetimibe tablet (Ezetrol ®) 10 mg.

Trial Locations (1)

Unknown

Clinical Research Center, Qingdao

All Listed Sponsors
lead

The Affiliated Hospital of Qingdao University

OTHER

NCT05681247 - Bioavailability and Bioequivalence of Ezetimibe Tablets in Healthy Subjects | Biotech Hunter | Biotech Hunter